Should the FDA consider cost-effectiveness when approving new drug applications?(Pro & Con)(Food and Drug Administration): An article from: Skin & Allergy News

This digital document is an article from Skin & Allergy News, published by International Medical News Group on September 1, 2004. The length of the article is 725 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Should the FDA consider cost-effectiveness when approving new drug applications?(Pro & Con)(Food and Drug Administration)
Author: Mark Hayman
Publication:Skin & Allergy News (Magazine/Journal)
Date: September 1, 2004
Publisher: International Medical News Group
Volume: 35 Issue: 9 Page: 11(1)

Distributed by Thomson Gale